| 注册
首页|期刊导航|中国医学创新|醒脑复元汤联合头穴埋线治疗阿尔茨海默病的临床研究

醒脑复元汤联合头穴埋线治疗阿尔茨海默病的临床研究

严明炎 夏北平 程麒麟

中国医学创新2026,Vol.23Issue(12):9-13,5.
中国医学创新2026,Vol.23Issue(12):9-13,5.DOI:10.3969/j.issn.1674-4985.2026.12.003

醒脑复元汤联合头穴埋线治疗阿尔茨海默病的临床研究

Clinical Study on Xingnao Fuyuan Decoction Combined with Scalp Acupoint Catgut Embedding in the Treatment of Alzheimer's Disease

严明炎 1夏北平 2程麒麟3

作者信息

  • 1. 随州市中医医院脑病科 湖北 随州 441300
  • 2. 随州市中医医院肺病科 湖北 随州 441300
  • 3. 随州市中心医院三门诊 湖北 随州 441300
  • 折叠

摘要

Abstract

Objective:To explore the clinical efficacy of Xingnao Fuyuan Decoction combined with scalp acupoint catgut embedding in addition to the conventional western medicine treatment in the treatment of Alzheimer's disease(AD),and to provide practical evidence for the integrated traditional Chinese and western medicine treatment of AD.Method:A total of 92 patients with AD were selected from Suizhou Hospital of Traditional Chinese Medicine from January 2023 to December 2024.They were randomly allocated into group A and group B,with 46 cases in each group.Group A received conventional western medicine treatment(Donepezil Hydrochloride Tablets),while group B received a combination of Xingnao Fuyuan Decoction and scalp acupoint catgut embedding based on the treatment of group A.Both groups were treated for one month.The TCM syndrome scores,cognitive function and dementia severity[Alzheimer's disease assessment scale-cognitive subscale(ADAS-Cog13),clinical dementia rating-sum of boxes(CDR-SB),and mini-mental state examination(MMSE)]before and after treatment,clinical efficacy,and adverse reactions were compared between the two groups.Result:After treatment,the TCM syndrome score in group B was significantly lower than that in group A(P<0.05).After treatment,the ADAS-Cog13 and CDR-SB scores in group B were lower than those in group A,while the MMSE score was higher than that in group A(P<0.05).The total effective rate was significantly higher in group B compared to group A(P<0.05).The incidence of adverse reactions in group B was similar to that in group A,with no statistically significant difference(P>0.05).Conclusion:On the basis of conventional western medicine therapy,the combination of Xingnao Fuyuan Decoction and scalp acupoint catgut embedding demonstrates a satisfactory clinical effect in treating AD.This combined regimen can alleviate patients'symptoms and dementia severity,improve cognitive function with fewer adverse reactions,indicating a combination of both effectiveness and safety.

关键词

醒脑复元汤/头穴埋线/阿尔茨海默病/认知功能/痴呆程度

Key words

Xingnao Fuyuan Decoction/Scalp acupoint catgut embedding/Alzheimer's disease/Cognitive function/Dementia degree

引用本文复制引用

严明炎,夏北平,程麒麟..醒脑复元汤联合头穴埋线治疗阿尔茨海默病的临床研究[J].中国医学创新,2026,23(12):9-13,5.

基金项目

湖北省中医药管理局中医科研项目(ZY2023M058) (ZY2023M058)

中国医学创新

1674-4985

访问量1
|
下载量0
段落导航相关论文